Friday 6 November 2026 Export SMMT’s income statement to Excel — free account

Summit Therapeutics PLC

SMMT Healthcare Biotechnology

Summit Therapeutics PLC’s revenue for fiscal 2022 (year ended December 2022) was $705,000.00.

EPS: +63.2%
Free cash flow: −112.8%

Quarter to June 2026, against a year earlier

Insider buying

15.57 1.38 +9.73%

Follow SMMT

Alert me

Market cap: $11.3B
P/E: 0.0×
Fwd P/E: 0.0×
Dividend yield: —
F-score: 3/9
Altman Z: 0.88
Beneish M: −5.00
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Summit Therapeutics PLC (SMMT) P/E ratio

Alert me on P/E ratio

Summit Therapeutics PLC has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 7.4× (September 2019) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/SMMT/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Summit Therapeutics PLC P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/SMMT/metrics/pe-ratio">Summit Therapeutics PLC (SMMT) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2019	0.6×	—
FY2018	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Dec 2022	0.0×	—
Sep 2022	0.0×	—
Jun 2022	0.0×	—
Mar 2022	0.0×	—
23 more quarters	Free account

Against its own ten years

Low 0.0× High 7.4×

Ten-year median 0.0×

Current reading's percentile 94

Company	P/E ratio
KYMR Kymera Therapeutics, Inc. compare	n/m
BMRN BioMarin Pharmaceutical Inc. compare	n/m
SMMT Summit Therapeutics PLC	n/m
BBIO BridgeBio Pharma, Inc. compare	n/m
PCVX Vaxcyte, Inc. compare	n/m
ASND Ascendis Pharma A/S compare	18.3×
HALO Halozyme Therapeutics, Inc. compare	29.5×
TECH Bio-Techne Corp compare	62.2×
JAZZ Jazz Pharmaceuticals PLC compare	62.6×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Summit Therapeutics PLC (SMMT) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on SMMT

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on SMMT

Stockrow Weekly